Recent thoracic artificial lung (TAL) prototypes have impedances lower than the natural lung. With these devices, proximal pulmonary artery (PA) to distal PA TAL attachment may be possible in patients without right ventricular dysfunction. This study examined the relationship between pulmonary system impedance and cardiac output (CO) to create TAL design constraints. A circuit with adjustable resistance and compliance (C) was attached in a PA-PA fashion with the pulmonary circulation of seven sheep with chronic pulmonary hypertension. The pulmonary system zeroth harmonic impedance modulus (Z 0 ) was increased by 1, 2.5, and 4 mmHg/(L/min) above baseline. At each Z 0 , C was set to 0, 0.34, and 2.1 ml/ mmHg. The change in pulmonary system zeroth and first harmonic impedance moduli (ΔZ 0 and ΔZ 1 ), the percent change in CO (%ΔCO), and the inlet and outlet anastomoses resistances were calculated for each situation. Results indicate that ΔZ 0 (p < 0.001) but not ΔZ 1 (p = 0.5) had a significant effect on %ΔCO and that %ΔCO = −7.45*ΔZ0 (R 2 = 0.57). Inlet and outlet anastomoses resistances averaged 0.77 ± 0.16 and 0.10 ± 0.19 mmHg/(L/min), respectively, and the relationship between %ΔCO and TAL resistance, R T , in mmHg/(L/ min) was determined to be %ΔCO = −(7.45f )×(R T + 0.87), in which f = the fraction of CO through the TAL. Thus, newer TAL designs can limit %ΔCO to less than 10% if f < 0.75. ASAIO Journal 2012;58:426-431.
Blood flow through thoracic artificial lungs (TALs) is driven by the right ventricle, and thus, TALs can cause significant changes in right ventricular (RV) function. Recently, laboratory studies have demonstrated successful long-term use of these devices when attached to the pulmonary circulation in parallel with the native lung. In-parallel attachment can significantly reduce pulmonary pressures and unload the right ventricle. [1] [2] [3] [4] Thus, this is the preferred method for artificial lung attachment in lung-transplant candidates with significant pulmonary hypertension and resultant RV dysfunction.
However, a significant subset of lung-transplant candidates do not have pulmonary hypertension (mean pulmonary artery [PA] pressure > 25 mmHg). This includes 69% of candidates with idiopathic pulmonary fibrosis, 5 50% with chronic obstructive pulmonary disease, 6 and 37% with cystic fibrosis. 7 These patients may tolerate a small increase in pulmonary system impedance without RV dysfunction. If so, PA to PA TAL attachment might be possible. The advantages of this attachment method are that emboli cannot escape into the systemic circulation to damage other major organs and that the entire cardiac output (CO) flows through the native lungs, allowing full processing of vasoactive molecules by the lungs. 8, 9 The major disadvantage of this attachment mode is that it automatically increases the impedance that the right ventricle must pump against, leading to decreased CO in the short term and potential RV failure. Thus, for PA-PA attachment to be feasible, TALs need to be designed with extremely low impedances. Recently, Schewe et al. 10 reported artificial lung designs with resistances approximately one third of previously reported devices. 11 It is unclear, however, if this reduction is sufficient for PA-PA attachment. The goal of this study, therefore, was to examine the design constraints of TALs for PA-PA attachment in a model of mild pulmonary hypertension. Accordingly, this study first examined the effect of pulmonary system impedance on short-term RV function in sheep with chronic pulmonary hypertension. Second, this study quantified the contribution of the PA anastomoses and grafts to the impedance of the pulmonary system during artificial lung attachment. From these results, design constraints for the artificial lung were created for patients with mild pulmonary hypertension.
Methods

Circuit and Compliance Chamber
The test circuit was connected to the pulmonary system via vascular graft anastomoses to the PA as shown in Figure 1 . The circuit is made of 5/8 inch inner diameter, 7/8 inch outer diameter, noncompliant polyvinylchloride tubing and a variable compliance (C) chamber, which has been described elsewhere. 12, 13 The C was varied using springs that give C = 0.34 and 2.1 ml/mmHg. To create a C = 0 situation, the chamber was bypassed during testing with an extra length of 5/8 inch ID, 7/8 inch OD PVC tubing.
Pulmonary Hypertension Model
A large animal model of pulmonary hypertension with RV hypertrophy was created using pulmonary embolization in adult male sheep. This model is characterized in detail elsewhere. 14 In brief, 0.75 gm of Sephadex G-50 (100-300 μm) beads (Sigma-Aldrich CO, St. Louis, MO) were injected into the pulmonary circulation every other day for 60 days. Mean PA pressures in these sheep were 28 ± 2 mmHg during surgery just before initiating the experimental procedure described below.
Experimental Procedure
Seven hypertensive sheep (65-75 kg) were used. All sheep were cared for in compliance with the Guide for the Care and Use of Laboratory Animals. Anesthesia was induced with an intravenous injection of 7-10 mg/kg sodium thiopental (Abbot Laboratories, Chicago, IL). Mechanical ventilation, anesthesia, arterial and venous pressure monitoring, and left thoracotomy followed previously published methods. 3 After thoracotomy, sheep were anticoagulated with 100 unit/kg of intravenous sodium heparin (Baxter Healthcare Corporation, Deerfield, IL). The inflow conduit was anastomosed in an end-to-side fashion to the proximal PA, and the outflow conduit was anastomosed in the same fashion to the distal PA. The conduits for the artificial lung were 18 mm, low-porosity woven Dacron vascular grafts (Boston Scientific, Natick, MA) bonded to 5/8-inch ID PVC tubing. Angiocatheters (16 gauge) were inserted into the proximal PA (immediately distal to the valve) and distal PA (immediately distal to the circuit outlet anastomosis) and attached to fluid-coupled pressure transducers (Abbot Critical Care Systems, Chicago, IL). These were then used to record continuous proximal and distal PA pressures (PpPA and PdPA, respectively). An ultrasonic flow probe (Transonic 24AX, Ithaca, NY) was placed around the proximal PA (immediately distal to the proximal PA angiocatheter and before the inlet conduit) to measure instantaneous PA flow (QPA) using a flow meter (Transonic TS420, Ithaca, NY).
Clamps on the inlet and the outlet conduits were removed, and the segment of PA between the proximal and distal PA anastomoses was snared to divert CO through the artificial circuit. An ultrasonic flow probe (Transonic 14XL) was placed on the outflow conduit tubing and connected to a flow meter (Transonic TS410) to record circuit flow, Q C . Blood was allowed to flow through the circuit for 10 minutes for equilibration before the circuit was clamped off again and a baseline (BL) hemodynamic data set was recorded. This data set consisted of P pPA , P dPA , Q PA , and Q C . Data were digitally acquired at a sampling frequency of 250 Hz via a 16-channel circuit board using LabVIEW software (National Instruments, Austin, TX).
The pulmonary system zeroth harmonic input impedance modulus (Z 0 , see Data Analysis) was increased by first snaring the main PA between the two grafts to divert flow into the artificial circuit. Then, after the full CO was diverted, the variable resistance, Hoffman clamp was tightened at the distal end of the artificial circuit. The Z 0 was increased by 1, 2.5, and 4 mmHg/(L/min) greater than BL. At each Z 0 , C was set at 0, 0.34, and 2.1 ml/mmHg to vary the pulmonary system first harmonic input impedance modulus (Z 1 , see Data Analysis). Each condition was held for 10 minutes before recording data. No inotropes, pressors, or volume support was used at any point in the experiment so as to highlight hemodynamic changes. At the end of the study, the animal was euthanized with an intravenous injection of pentobarbital (Fatal-Plus, 90-150 mg/ kg, Vortech Pharmaceuticals, Dearborn, MI).
Data Analysis
Calculation of Z 0 , Z 1 , and CO are described in detail elsewhere. 15, 16 The change in Z 0 and Z 1 from BL (ΔZ 0 and ΔZ 1 ) was also calculated for each situation as
To ensure the C chamber was functioning properly, the change in pulsatility across the circuit was calculated. The pulsatility of blood flow, P, in both the PA and circuit outlet was calculated according to previous methods. 13 The pulsatility decrease, ΔP, caused by the C chamber was calculated as PA P minus circuit outlet P.
The resistance of the inlet anastomosis was calculated as
, in which P pPA is the average proximal PA pressure, P I is the average circuit inlet pressure, and Q C is the average circuit blood flow rate. The resistance of the outlet anastomosis was calculated as
-, in which P O is the average circuit outlet pressure and P dPA is the average distal PA pressure.
The relationship between impedance, RV power output, and CO was examined by calculating the stroke power output from the right ventricle. Three conditions were examined to capture the loading extremes in the study: BL (low ΔZ 0 and low ΔZ 1 ); ΔZ 0 = 4 mmHg/(L/min), C = 0 (high ΔZ 0 and high ΔZ 1 ); and ΔZ 0 = 4 mmHg/(L/min), C = 2 (high ΔZ 0 and low ΔZ 1 ). In all cases, total power, POW T , was calculated as (6) in which T is the data period. The power present in the zeroth and first harmonic (POW 0 and POW 1 ) were calculated as Q 0 2 Z 0 and 0.5Q 1 2 Z 1 cosφ Zi respectively, in which φ Zi is the first harmonic phase shift of the impedance. 17 The percentage of power in the ith harmonic is thus calculated as 100×POW i /POW T .
Data Analysis-Statistics
Statistical analyses used SPSS software (SPSS, Chicago, IL). Mixed model analysis was used to determine if ΔZ 0 and ΔZ 1 had a significant effect on dependent variables %ΔCO, mean arterial pressure (MAP), central venous pressure (CVP), and heart rate (HR). The sheep number was the subject variable; ΔZ 0 was a fixed, independent variable; and ΔZ 1 was a covariate. On the basis of this statistical analysis (see Results), linear regression was performed within SPSS to generate the following relationship: %ΔCO = mΔZ 0 (7) Last, linear regression was performed to relate the inlet and outlet anastomoses resistances (R i and R o ) to the flow rate through the TAL, Q C .
Data Analysis-Relationship Between TAL Resistance and CO
The correlation %ΔCO = mΔZ 0 relates %ΔCO to the impedance change of the entire pulmonary system. To isolate the acceptable TAL resistance during PA-PA attachment, a relationship was created between R T , the fraction of blood flow going to the TAL (f ), and the anastomosis impedances. Figure 2 presents a diagram of PA-PA attachment, in which Z b , Z ia , Z oa , and Z T are the impedances of the PA band, the inlet anastomosis, the outlet anastomosis, and the TAL, respectively. If one assumes the impedance of the natural lung is unchanged by TAL attachment, the change in the impedance of the system because of the TAL, ΔZ, is:
The fraction of the CO flowing to the artificial lung, f, is characterized by:
Substituting, equation 9 with 8 and solving for Z T gives:
The equation retains its form considering the zeroth harmonic only:
Substituting in equation 7 yields:
The zeroth harmonic impedances for the TAL and anastomoses are equal to their resistances, R T , R i , and R o . Thus, the desired relationship between R T and %ΔCO is: Tables 1 and 2 show the actual average ΔZ 0 and ΔZ 1 , respectively, of each hemodynamic situation. Values for ΔZ 0 were close but typically a bit lower than our goals. Table 2 shows that ΔZ 1 increases with increasing ΔZ 0 and decreasing C. Overall, changes in ΔZ 1 were small for C ≥ 0.3 ml/mmHg and ΔZ 0 = 1 mmHg/(L/min) but markedly increased for C = 0 and ΔZ 0 ≥ 2.5 mmHg/(L/min). Figure 3 shows representative P PA and Q PA waveforms for BL and ΔZ 0 = 4 mmHg/(L/min) at C = 0 and 2.1 ml/mmHg. Figure 4 demonstrates the decrease in pulsatility between Q PA and Q C . The decrease in pulsatility increases with C, indicating the C chamber is functioning appropriately. Table 3 demonstrates the effect of each ΔZ 0 and ΔZ 1 condition on HR, MAP, and CVP. Neither ΔZ 0 nor ΔZ 1 has a significant effect on HR (p = 0.17 and 0.54, respectively) or MAP (p = 0.97 and 0.98, respectively). Central venous pressure, however, increases significantly with increasing ΔZ 0 (p < 10 −5 ) but does not change significantly with C (p = 0.28). Figure 5 demonstrates the effect of ΔZ 0 on CO at varying C. The percentage change in CO decreases linearly with ΔZ 0 , but C does not affect CO. Accordingly, the effect of ΔZ 0 is statistically significant (p < 0.001), whereas the effect of ΔZ 1 is not (p = 0.5). A curve fit yields the relationship %ΔCO = −7.45ΔZ 0 (R² = 0.57). Figure 6 demonstrates the percentage of the stroke power from the heart in the zeroth and first harmonic at BL and when ΔZ 0 = 4 mmHg/(L/min) at C = 0 and 2 ml/mmHg. The percentage of stroke power in the zeroth and first harmonics range from 82% to 85% and 2% to 5%, respectively. Thus, it can be seen that the workload of the RV is dominated by the zeroth harmonic within relevant ranges of loading conditions.
Results
Confirmation of Study Design
Effect of Impedance on Hemodynamics
Anastomosis Resistances
Linear regression between R i and R o and Q C demonstrated weak relationships with a large degree of scatter (R 2 = 0.10 and 0.05, respectively). Therefore, physical differences in anastomosis construction and pressure-catheter placement seem to have as great an effect on resistance as flow rate. Therefore, all anastomosis resistances were regarded as constants and averaged across device-flow rates ranging from 2.5 to 5.2 L/min, leading to R i = 0.77 ± 0.16 mmHg/(L/min) and R o = 0.10 ± 0.19 mmHg/(L/min).
TAL Resistance Requirements
Results for m, R i , and R o were substituted into equation 10 to yield %ΔCO = −(7.45f)×(R T + 0.87) or, solving for R T , R T = −%ΔCO/(7.45f)−0.87. Figure 7 shows the resistance requirements for the TAL graphed versus −%ΔCO at f = 0.5, 0.75, and 1.0. If one would like to limit the drop in CO to less than 10%, for example, one must hold the TAL resistance less than 1.81, 0.92, and 0.47 for 50, 75, and 100% blood flow to the TAL.
Discussion
The goal of this study was to determine a relationship between CO and impedance of the artificial lung during PA-PA attachment with the natural lungs. The first major finding of this study is that the first harmonic impedance modulus, Z 1 , has no effect on CO in a model of chronic pulmonary hypertension. Thus, in a clinical setting, artificial lung C should not significantly affect CO. The implication of this finding is that one can design TALs by focusing solely on minimizing Z 0 or, equivalently, TAL resistance.
The finding that Z 1 has no effect on CO seems to contradict a decade worth of research in this area. Studies by several authors have demonstrated lower RV workloads and improved CO using an inlet C chamber. 1, 2, 12, 13 Most notably, Sato et al. 13 attached the Biolung (MC3, Ann Arbor, MI) in a PA to PA fashion with 100% of CO flowing through the TAL, and found that CO fell 42% with C = 0.5 ml/mmHg but only 25% when C ≥ 1.0 ml/mmHg. Under these conditions ΔZ 0 was approximately 4 mmHg/(L/ min). Kuo et al. 16 performed experiments similar to those in this article in normal sheep, and found a small but statistically significant effect of Z 1 on CO.
The major difference between those two studies and the current one is that they were conducted using normal sheep. The sheep pulmonary hypertension model used here have RV hypertrophy and normal CO despite mean PA pressures of 35 mmHg when awake. 14 It is likely, therefore, that the hypertrophied RV is less affected by the ΔZ 1 than the normal RV is. Furthermore, as Figure 6 demonstrates, the first harmonic adds less than 5% to RV stroke power requirements and thus only a small change in the oxygen-consumption requirements. As a result of its design, this study was not able to determine the total power requirements of the RV, including dissipated power, but it is likely that the contribution of Z 1 remains very small.
Ultimately, this means that the artificial lung design requirements can focus only on the zeroth harmonic and system resistances. The relationship between CO, TAL resistance, and the fraction of CO going to the TAL was thus found to be %ΔCO = −(7.45f )×(R T + 0.87). One previous study 15 examined the relationship between %ΔCO and ΔZ 0 alone in both healthy and hypertensive sheep, generating the relationship %ΔCO = 0.215ΔZ 0 2 −7.14ΔZ 0 + 2.94. The effect of Z 1 was not considered. As in Figure 7 , one can use this relationship to determine the relationship between %ΔCO and R T . That relationship is: %ΔCO = 0.215f 2 (0.87 + R T ) 2 −7.14 f (0.87 + R T )+2.94 (7) In that study, if the design goal was %ΔCO < 10%, R T would need to be less than 1.05 and 1.70 with 100 and 75% of CO flowing through the TAL, respectively. The current study predicts a more conservative estimate for the design requirements of the TAL, with R T < 0.47 and 0.92 under the same conditions. Even under the more conservative estimate from this study, it should be possible to achieve a PA-PA attachment that offers significant oxygen transfer with %ΔCO < 10%. Schewe et al. 11 presented the lowest impedance TAL in the literature, a solid shell TAL with R T = 0.69 ± 0.13 mmHg/(L/min). The predicted drop in CO is 8.8% for PA-PA attachment with 75% of CO flowing to this TAL.
The first limitation of this study and these relationships is that only the short-term hemodynamic effect of attachment was examined. Further studies will need to be performed to determine the effect of attachment for a period of a few weeks to a month. It is unclear how long it would take for RV accommodation and whether pressor support would be needed for a short period. Phenylephrine has been shown to increase CO under similar high-RV afterload conditions because it raises arterial pressures and coronary perfusion 18, 19 but has minimal effect on pulmonary vascular resistance. The second limitation of this study is that delivery of oxygenated blood to the pulmonary circulation may act to lower PVR. The extent to which this would ameliorate the effects of the added device resistance is unknown. The last limitation of this study is that PA-PA attachment in humans would be significantly more difficult than in sheep. The human main PA is very short in comparison to the sheep, and thus the outlet anastomosis would likely have to be placed upon a branch of the main PA. The effect of this change on total impedance should be small, however, as the impedance of the outlet anastomoses is small.
Pulmonary artery to left atrium attachment would be far more favorable for use on the order of weeks because of the relatively small risk of systemic embolization. For use over a longer term, however, the lack of systemic embolization may outweigh risks of proximal PA-PA branch attachment. In PA-LA attachment of 1 month, uncoated TAL prototypes have demonstrated minimal changes to systemic hematology, despite clotting and subsequent device replacement after an average of 9.5 days, and there was no need to infuse blood products. Evidence of minor embolic events was present, however. If repeated, small embolic events are the greatest problem during long-term use; therefore, PA-PA use on the order of months may be beneficial.
